27.54
Enovis Corp stock is traded at $27.54, with a volume of 1.13M.
It is up +1.40% in the last 24 hours and down -14.29% over the past month.
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
See More
Previous Close:
$27.16
Open:
$27.09
24h Volume:
1.13M
Relative Volume:
0.81
Market Cap:
$1.57B
Revenue:
$2.15B
Net Income/Loss:
$-809.46M
P/E Ratio:
-1.9742
EPS:
-13.95
Net Cash Flow:
$-38.98M
1W Performance:
+4.75%
1M Performance:
-14.29%
6M Performance:
-42.37%
1Y Performance:
-41.29%
Enovis Corp Stock (ENOV) Company Profile
Name
Enovis Corp
Sector
Industry
Phone
(302) 252-9160
Address
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ENOV
Enovis Corp
|
27.54 | 1.55B | 2.15B | -809.46M | -38.98M | -13.95 |
![]()
ABT
Abbott Laboratories
|
126.54 | 218.59B | 43.11B | 13.98B | 6.66B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
106.14 | 157.13B | 18.49B | 2.51B | 2.72B | 1.68 |
![]()
SYK
Stryker Corp
|
403.53 | 151.59B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
92.94 | 118.29B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
80.00 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-03-24 | Initiated | JMP Securities | Mkt Outperform |
Jun-13-24 | Initiated | JP Morgan | Neutral |
Feb-13-24 | Initiated | Stephens | Overweight |
Jan-22-24 | Initiated | UBS | Buy |
Jan-03-24 | Initiated | William Blair | Outperform |
Dec-15-23 | Reiterated | Needham | Buy |
Oct-20-23 | Initiated | ROTH MKM | Buy |
Jun-26-23 | Initiated | Needham | Buy |
May-12-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Oct-12-22 | Initiated | Jefferies | Buy |
Oct-11-22 | Initiated | Goldman | Buy |
Sep-12-22 | Initiated | Canaccord Genuity | Buy |
Sep-12-22 | Initiated | Evercore ISI | Outperform |
Jun-28-22 | Initiated | Argus | Hold |
Jun-27-22 | Resumed | Loop Capital | Buy |
Jun-16-22 | Initiated | Wells Fargo | Equal Weight |
View All
Enovis Corp Stock (ENOV) Latest News
What analysts say about Enovis Corporation stockLightning-fast capital gains - Autocar Professional
What drives Enovis Corporation stock priceFree Trading Psychology Coaching - Autocar Professional
Is Enovis Corporation a good long term investmentHigh-yield growth strategies - PrintWeekIndia
Enovis Corporation Stock Analysis and ForecastFree Real-Time Stock Data - PrintWeekIndia
What analysts say about Enovis Corporation stock outlookHigh-performance investment picks - jammulinksnews.com
Enovis (NYSE:ENOV Shareholders Incur Further Losses as Stock Declines 12% This Week, Taking Five-year Losses to 48% - 富途牛牛
Published on: 2025-07-23 01:36:14 - jammulinksnews.com
Enovis Corporation (NYSE:ENOV) Stock Rises Amid Market OptimismNews and Statistics - IndexBox
Enovis Corporation's (NYSE:ENOV) Shares Lagging The Industry But So Is The Business - simplywall.st
Enovis (ENOV) Stock Trades Up, Here Is Why - TradingView
Enovis Shares Plunge 14.81% Amid Accounting Concerns - AInvest
Enovis, CONMED, Astrana Health, Privia Health, and Waters Corporation Stocks Trade Down, What You Need To Know - Yahoo Finance
Enovis stock hits 52-week low at 28.81 USD - Investing.com
Enovis stock hits 52-week low at 28.81 USD By Investing.com - Investing.com Canada
Enovis stock ticks down after Jehoshaphat Research reveals short position By Investing.com - Investing.com India
Enovis stock ticks down after Jehoshaphat Research reveals short position - Investing.com
Jehoshaphat Research Says We Are Short Enovis - TradingView
Evercore ISI Maintains a Buy on Enovis Corporation (ENOV) With a $46 PT - MSN
What makes Enovis Corporation stock price move sharplyEntry Level Low Risk Picks - Newser
Why Enovis Corporation stock attracts strong analyst attentionGrowth Stock Monitor - newser.com
Enovis Corporation to Announce Q2 2025 Results via Investor Call and Webcast - MSN
Guardant Health, Gilead Sciences, Inspire Medical Systems, Enovis, and AMN Healthcare Services Stocks Trade Down, What You Need To Know - MSN
User - FinancialContent
Orthopedic Appliances Market Size, Share, Growth and Report - openPR.com
Evercore ISI Cuts Enovis (NYSE:ENOV) Price Target to $46.00 - Defense World
Enovis to Host Second Quarter 2025 Results Conference Call on August 7th - The Manila Times
Enovis Corporation Announces Q2 2025 Earnings Call and Webcast - AInvest
Enovis Corporation to Host Investor Conference Call for Second Quarter 2025 Financial Results - Nasdaq
Evercore ISI Group Lowers Price Target for Enovis (ENOV) to $46. - GuruFocus
Assessing Enovis: Insights From 4 Financial Analysts - Nasdaq
Enovis: Evercore ISI Group maintains Outperform, PT down to $46 from $48. - AInvest
Enovis Corporation(NYSE: ENOV) dropped from Russell 1000 Index - MarketScreener
Enovis Corporation (ENOV): A Contrarian Play in MedTech Amid AI Hype - AInvest
Enovis (ENOV): Navigating Tariff Headwinds to Capture Margin Resilience - AInvest
5 Insightful Analyst Questions From Enovis’s Q1 Earnings Call - Yahoo Finance
Entegris, Herc, Enovis, Commercial Vehicle Group, and DexCom Shares Skyrocket, What You Need To Know - FinancialContent
Enovis stock hits 52-week low at 29.11 USD - Investing.com
Enovis Corporation Performance Slips Against NYSE Composite - Kalkine Media
Enovis (NYSE:ENOV shareholders incur further losses as stock declines 3.0% this week, taking five-year losses to 34% - simplywall.st
Enovis Corp Stock (ENOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):